These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33215299)

  • 41. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
    Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transdermal iontophoresis of salmon calcitonin can reproduce the hypocalcemic effect of intravenous administration.
    Santi P; Volpato NM; Bettini R; Catellani PL; Massimo G; Colombo P
    Farmaco; 1997; 52(6-7):445-8. PubMed ID: 9372596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapidly dissolving bilayer microneedle arrays - A minimally invasive transdermal drug delivery system for vitamin B12.
    Ramöller IK; Tekko IA; McCarthy HO; Donnelly RF
    Int J Pharm; 2019 Jul; 566():299-306. PubMed ID: 31150773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery.
    Lau S; Fei J; Liu H; Chen W; Liu R
    J Control Release; 2017 Nov; 265():113-119. PubMed ID: 27574991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.
    Tewes F; Gobbo OL; Amaro MI; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
    Mol Pharm; 2011 Oct; 8(5):1887-98. PubMed ID: 21882837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissolving microneedle based transdermal delivery of therapeutic peptide analogues.
    Dillon C; Hughes H; O'Reilly NJ; Allender CJ; Barrow DA; McLoughlin P
    Int J Pharm; 2019 Jun; 565():9-19. PubMed ID: 31047995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statistically optimized fast dissolving microneedle transdermal patch of meloxicam: A patient friendly approach to manage arthritis.
    Amodwala S; Kumar P; Thakkar HP
    Eur J Pharm Sci; 2017 Jun; 104():114-123. PubMed ID: 28385631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PHEA-graft-polymethacrylate supramolecular aggregates for protein oral delivery.
    Licciardi M; Pasut G; Amato G; Scialabba C; Mero A; Montopoli M; Cavallaro G; Schiavon O; Giammona G
    Eur J Pharm Biopharm; 2013 May; 84(1):21-8. PubMed ID: 23275110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis.
    Santi P; Colombo P; Bettini R; Catellani PL; Minutello A; Volpato NM
    Pharm Res; 1997 Jan; 14(1):63-6. PubMed ID: 9034222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel scalable fabrication process for the production of dissolving microneedle arrays.
    Chen H; Wu B; Zhang M; Yang P; Yang B; Qin W; Wang Q; Wen X; Chen M; Quan G; Pan X; Wu C
    Drug Deliv Transl Res; 2019 Feb; 9(1):240-248. PubMed ID: 30341765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery.
    Lee HE; Lee MJ; Park CR; Kim AY; Chun KH; Hwang HJ; Oh DH; Jeon SO; Kang JS; Jung TS; Choi GJ; Lee S
    J Control Release; 2010 Apr; 143(2):251-7. PubMed ID: 20026364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
    McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M
    Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Skin-targeted delivery of extracellular vesicle-encapsulated curcumin using dissolvable microneedle arrays.
    Yerneni SS; Yalcintas EP; Smith JD; Averick S; Campbell PG; Ozdoganlar OB
    Acta Biomater; 2022 Sep; 149():198-212. PubMed ID: 35809788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy.
    Tas C; Joyce JC; Nguyen HX; Eangoor P; Knaack JS; Banga AK; Prausnitz MR
    J Control Release; 2017 Dec; 268():159-165. PubMed ID: 29051065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy.
    Youn YS; Jung JY; Oh SH; Yoo SD; Lee KC
    J Control Release; 2006 Sep; 114(3):334-42. PubMed ID: 16884808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
    Bhandari KH; Newa M; Chapman J; Doschak MR
    J Control Release; 2012 Feb; 158(1):44-52. PubMed ID: 22001608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
    du Plessis LH; Lubbe J; Strauss T; Kotzé AF
    Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chitosan microneedle patches for sustained transdermal delivery of macromolecules.
    Chen MC; Ling MH; Lai KY; Pramudityo E
    Biomacromolecules; 2012 Dec; 13(12):4022-31. PubMed ID: 23116140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on pulmonary delivery system of salmon calcitonin in rats].
    Wang Z; Zhang Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 35(3):329-32. PubMed ID: 12914259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymeric Microarray Patches for Enhanced Transdermal Delivery of the Poorly Soluble Drug Olanzapine.
    McKenna PE; Abbate MTA; Vora LK; Sabri AH; Peng K; Volpe-Zanutto F; Tekko IA; Permana AD; Maguire C; Dineen D; Kearney MC; Larrañeta E; Paredes AJ; Donnelly RF
    ACS Appl Mater Interfaces; 2023 Jul; 15(26):31300-31319. PubMed ID: 37349320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.